MC
FOMX

Menta Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Menta Capital’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-56,378
Closed -$279K – 980
2017
Q1 		$279K Sell
56,378
-48,502
-46% -$467K 0.03% 692
2016
Q4 		$1.16M Sell
104,880
-18,243
-15% -$172K 0.1% 373
2016
Q3 		$1.14M Sell
123,123
-22,385
-15% -$187K 0.11% 319
2016
Q2 		$924K Buy
145,508
+32,697
+29% +$217K 0.13% 271
2016
Q1 		$736K Buy
112,811
+3,800
+3% +$24.5K 0.1% 332
2015
Q4 		$884K Buy
109,011
+17,200
+19% +$129K 0.11% 303
2015
Q3 		$673K Buy
91,811
+4,902
+6% +$50K 0.11% 350
2015
Q2 		$891K Buy
86,909
+21,350
+33% +$236K 0.15% 288
2015
Q1 		$606K Buy
+65,559
New +$587K 0.08% 394

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Menta Capital's FOMX Position: Q2 2017 in Review

Menta Capital sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2017, closing a stake of 56,378 shares — an estimated $279K sold.

Menta Capital first reported a position in FOMX in Q1 2015 and held it in 9 quarters. The position peaked at $1.16M in Q4 2016. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2017.

  • Menta Capital reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Menta Capital sold 56,378 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2017, an estimated $279K.
  • Menta Capital first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 9 quarters.
  • Menta Capital's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.16M in Q4 2016.
  • 56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2017.

Based on Menta Capital's 13F filing for Q2 2017, filed 11 Aug 2017.